Technology

Stocks Shrug Off Tariff Ruling, Weak GDP: Stock Market Today

2026-02-20 21:06
918 views
Stocks Shrug Off Tariff Ruling, Weak GDP: Stock Market Today

Market participants had plenty of news to sift through on Friday, including updates on inflation and economic growth and a key court ruling.

  1. Home
  2. Investing
  3. Stocks
Stocks Shrug Off Tariff Ruling, Weak GDP: Stock Market Today

Market participants had plenty of news to sift through on Friday, including updates on inflation and economic growth and a key court ruling.

Karee Venema's avatar By Karee Venema published 20 February 2026 in News

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

  • Copy link
  • Facebook
  • X
Share this article Print Join the conversation Follow us Add us as a preferred source on Google Newsletter Get the Kiplinger Newsletter

Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Contact me with news and offers from other Future brands Receive email from us on behalf of our trusted partners or sponsors By submitting your information you agree to the Terms & Conditions and Privacy Policy and are aged 16 or over.

You are now subscribed

Your newsletter sign-up was successful

Want to add more newsletters?

Kiplinger Today

Delivered daily

Kiplinger Today

Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more delivered daily. Smart money moves start here.

Signup + Kiplinger A Step Ahead

Sent five days a week

Kiplinger A Step Ahead

Get practical help to make better financial decisions in your everyday life, from spending to savings on top deals.

Signup + Kiplinger Closing Bell

Delivered daily

Kiplinger Closing Bell

Get today's biggest financial and investing headlines delivered to your inbox every day the U.S. stock market is open.

Signup + Kiplinger Adviser Intel

Sent twice a week

Kiplinger Adviser Intel

Financial pros across the country share best practices and fresh tactics to preserve and grow your wealth.

Signup + Kiplinger Tax Tips

Delivered weekly

Kiplinger Tax Tips

Trim your federal and state tax bills with practical tax-planning and tax-cutting strategies.

Signup + Kiplinger Retirement Tips

Sent twice a week

Kiplinger Retirement Tips

Your twice-a-week guide to planning and enjoying a financially secure and richly rewarding retirement

Signup + Kiplinger Adviser Angle

Sent bimonthly.

Kiplinger Adviser Angle

Insights for advisers, wealth managers and other financial professionals.

Signup + Kiplinger Investing Weekly

Sent twice a week

Kiplinger Investing Weekly

Your twice-a-week roundup of promising stocks, funds, companies and industries you should consider, ones you should avoid, and why.

Signup + Kiplinger Invest for Retirement

Sent weekly for six weeks

Kiplinger Invest for Retirement

Your step-by-step six-part series on how to invest for retirement, from devising a successful strategy to exactly which investments to choose.

Signup + An account already exists for this email address, please log in. Subscribe to our newsletter

digital rendition of blue stock chart with teal bars

(Image credit: Getty Images)

Stocks were volatile on Friday as market participants sifted through an onslaught of headlines – including the Supreme Court's ruling that most of President Donald Trump's tariff policies are illegal. The price action stabilized in afternoon trading, though, with the three main indexes finishing the day in positive territory.

At the close, the blue-chip Dow Jones Industrial Average was up 0.5% at 49,625, the broader S&P 500 was 0.7% higher at 6,909, and the tech-heavy Nasdaq Composite had gained 0.9% to 22,886.

Ahead of the Supreme Court's monumental decision – which was widely expected by many on Wall Street – markets were hit with a round of worse-than-anticipated economic reports.

From just $107.88 $24.99 for Kiplinger Personal Finance

Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues

CLICK FOR FREE ISSUE https://cdn.mos.cms.futurecdn.net/flexiimages/y99mlvgqmn1763972420.png

Sign up for Kiplinger’s Free Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

The Personal Consumption Expenditures (PCE) Price Index for December was up 0.4% month over month and 2.9% year over year. Excluding volatile food and energy prices, PCE rose 0.4% from November to December and 3% from the year-ago period.

The monthly figures were slightly higher than economists expected and faster than what was seen in November.

The PCE data, which is the Federal Reserve's preferred measure of inflation, follows Wednesday's release of the minutes from the January Fed meeting that showed "a number of" central bank officials were willing to keep interest rates unchanged "until there was clear indication that the progress of disinflation was firmly on track."

The Bureau of Economic Analysis also said this morning that the U.S. economy grew at an annual rate of 1.4% in the fourth quarter – much slower than the 2.5% rate many economists estimated.

The BEA cited a downturn in federal spending as one reason gross domestic product (GDP) decelerated in the final three months of 2025, a period that included the longest government shutdown on record.

"The Q4 GDP and December PCE data showed an unwelcome mix of lower growth than expected and a higher inflation read," says Stephen Coltman, head of macro at 21shares.

However, Coltman notes that the impact is somewhat muted "by the fact that this data is quite lagged, and does not match the trend in the more recent data we have seen for January (jobs, ISM surveys, CPI)."

The Supreme Court strikes down Trump's tariffs

Attention quickly turned to the Supreme Court's 6-3 ruling that found the International Emergency Economic Powers Act does not allow the president to impose tariffs.

"Had Congress intended to convey the distinct and extraordinary power to impose tariffs, it would have done so expressly," wrote Chief Justice John Roberts in the decision (pdf).

Looking for more timely stock market news to help gauge the health of your portfolio? Sign up for Closing Bell, our free newsletter that's delivered straight to your inbox at the close of each trading day.

"While the decision is meaningful from a legal standpoint, it does not represent a wholesale reversal of U.S. trade policy," says Jason Pride, chief of investment strategy and research at Glenmede. "The administration retains multiple alternative authorities that could allow tariffs to be re-implemented in largely similar form, suggesting continuity rather than disruption in the overall tariff regime."

Indeed, in a mid-afternoon press conference, Trump, who said the ruling was "deeply disappointing," announced a 10% global tariff using Section 122 of the Trade Act of 1974, which allows the president to impose tariffs for 150 days.

LyondellBasell halves its dividend

In single-stock news, LyondellBasell Industries (LYB, +2.4%) slashed its quarterly dividend to 69 cents per share from $1.37 per share.

The chemical company, which makes materials such as plastics and fuels, has seen its top and bottom lines decline in recent years amid oversupply and demand issues.

Track all markets on TradingView

"With markets expected to remain challenged, we have made the decision to recalibrate the dividend to better position the company to thrive once markets recover," said CEO Peter Vanacker in the press release.

UBS Global Research analyst Lucas Beaumont forecast a dividend cut following LYB's fourth-quarter earnings miss in January.

"If LYB wants to remain comfortably above $1-1.5 billion in cash balances for the next two years, we think the dividend needs to be cut by ~50%," Beaumont wrote in a January 30 note. The analyst has a Sell rating on the large-cap stock and a $42 price target, representing implied downside of 25% to current levels.

GRAIL sinks 50% on failed cancer drug study

GRAIL (GRAL) was one of the more noteworthy movers on Friday, with the health care stock sinking 50.6%.

Track all markets on TradingView

Pressuring shares were disappointing trial results for the company's multi-cancer screen test, which did not meet its primary endpoint.

GRAIL currently sells its Galleri cancer screening test and saw U.S. revenue for the product rise 26% year over year in Q4. The company is aiming to get Food and Drug Administration (FDA) approval for the test to widen its commercial base.

Related content

  • 5 Investing Rules You Can Steal From Millennials
  • Best Blue Chip Stocks: 21 Hedge Fund Top Picks
  • How to Master Index Investing
TOPICS S&P 500 Dow Jones Nasdaq Closing Bell Get Kiplinger Today newsletter — freeContact me with news and offers from other Future brandsReceive email from us on behalf of our trusted partners or sponsorsBy submitting your information you agree to the Terms & Conditions and Privacy Policy and are aged 16 or over. Karee VenemaKaree VenemaSocial Links NavigationSenior Investing Editor, Kiplinger.com

With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at a local investment research firm. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.

Latest You might also like View More \25b8